Cancer Analysis Firm PGDx Licenses Genome Mapping Technology from Johns Hopkins | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer genetic analysis firm Personal Genome Diagnostics today announced it has licensed the exclusive rights to the Digital Karyotyping genome mapping technology from Johns Hopkins University.

The technology was developed by the company's founders, who also hold positions at the university. Under the terms of the deal, PGDx can sublicense the DK technology to third parties. Further details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.